Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov;24(11):2031-9.
doi: 10.1007/s11095-007-9336-y. Epub 2007 May 31.

Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man

Klaas P Zuideveld  1 , Piet H Van der Graaf, Lambertus A Peletier, Meindert Danhof
Affiliations

Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man

Klaas P Zuideveld et al. Pharm Res. 2007 Nov.

Abstract

Purpose: The aim of the present study was to assess whether two widely used biomarkers for 5-HT(1A)-receptor mediated responses in the rat (hypothermia and corticosterone increase) could be scaled to man using allometric principles.

Materials and methods: Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models were developed and characterized in rats for the standard 5-HT(1A)-receptor agonists, buspirone and flesinoxan. Allometric scaling was investigated on the basis of simulation taking into account the inter-individual variability and clinical study design. The model-predicted effects of both flesinoxan and buspirone were compared to those published in the literature.

Results: The main finding of this analysis was that for both hypothermia and cortisol increase, the model could predict the extent of the pharmacological response in man adequately. For the hypothermic response, the time course of the response was also predicted with a high degree of accuracy. In contrast, in the case of the cortisol response, the observed time lag was, despite the fact that it fell within the model uncertainty, not predicted.

Conclusions: Based on these analyses, it is concluded that allometrically scaled mechanism based PK-PD models are promising as a means of predicting the pharmacodynamic responses in man. This approach provides for a novel way of interpreting and scaling pre-clinical pharmacological responses and ultimately facilitates the understanding and prediction of pharmacological responses in man.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Pharmacol Exp Ther. 2004 Mar;308(3):1012-20 - PubMed
    1. J Vet Pharmacol Ther. 2004 Aug;27(4):211-8 - PubMed
    1. Am J Physiol. 1995 Jan;268(1 Pt 2):R85-91 - PubMed
    1. Biol Psychiatry. 1993 Nov 1;34(9):665-6 - PubMed
    1. Neuropsychopharmacology. 1995 Oct;13(2):93-104 - PubMed

LinkOut - more resources